NAPLES, Fla., Aug. 17, 2021 /PRNewswire/ — HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients, and medical data, reported its financial results for the three and six months ended June 30, 2021. The Company’s second quarter 2021 (“2Q’21”) results were excellent, with revenue up 47% compared to second quarter 2020 and first half 2021 (“1H’21”) revenue up 40% over first half 2020 (“1H’20”).
First Half 2021 Compared to First Half 2020:
Second Quarter 2021 Compared to Second Quarter 2020:
Second Quarter 2021 Compared to First Quarter 2021:
“We are pleased that we were able to significantly grow patient volume, time of service collections and revenue in our Health Services division in second quarter compared to the same period last year,” stated Dr. Michael Dent CEO.
George O’Leary, HealthLynked CFO stated “Revenue was up 47% from second quarter of last year and down only 4% from last quarter.” He continued, “We also wiped out $632k of current debt this quarter without any cash outflow through PPP Loan forgiveness, further improving our balance sheet. Our net equity maintained at $6.3 million for Q2 2021, leaving us in a strong position for our planned uplisting during the second half of the year.”
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries, and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent-pending patient access hub “PAH” for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last-minute cancelations using the Company’s “real-time appointment scheduling” all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.
Forward-Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
Contacts:
George O’Leary
Chief Financial Officer
goleary@healthlynked.com
(800)-928-7144, ext. 103
William Hayde
Capital Markets Strategist
bhayde@healthlynked.com
(631)-403-4337
Investor Relations Contacts:
Jim Hock
Hanover International Inc.
jh@hanoverintlinc.com
(760)-564-7400
HealthLynked Corp. |
|||||||||||
Selected Consolidated Financial Data |
|||||||||||
Three and Six Months Ended June 30, 2021 and 2020 |
|||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||
2021 |
2020 |
2021 |
2020 |
||||||||
Statement of Operations Data |
|||||||||||
Total revenue |
$ |
1,710,620 |
$ |
1,161,510 |
$ |
3,495,314 |
$ |
2,498,450 |
|||
Net loss |
$ |
(505,764) |
$ |
(1,517,848) |
$ |
(8,329,217) |
$ |
(2,098,064) |
|||
Net loss per share to |
$ |
(0.00) |
$ |
(0.01) |
$ |
(0.04) |
$ |
(0.02) |
|||
Weighted average |
228,007,727 |
125,535,787 |
220,643,390 |
118,881,613 |
|||||||
Balance Sheet Data |
|||||||||||
June 30, 2020 |
Dec. 31, 2019 |
||||||||||
Total Assets |
$ |
10,332,967 |
$ |
8,026,548 |
|||||||
Total Liabilities |
$ |
4,030,734 |
$ |
6,676,540 |
|||||||
Total Shareholders’ Equity |
$ |
6,302,233 |
$ |
1,350,008 |
View original content:https://www.prnewswire.com/news-releases/healthlynked-reports-47-year-over-year-revenue-growth-for-second-quarter-2021-40-growth-year-to-date-301356261.html
SOURCE HealthLynked Corp.
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…